Tradestie Institutional Equity Comparison Engine · Market Close Aug 25, 2026

ABVE vs OSRH: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ABVE Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 5–3 Matrix Metrics)

ABVE Overall Winner 6-Pillar Tally: ABVE 6 – 0 OSRH Matrix Metrics: ABVE 5 – 3 OSRH

As of Aug 25, 2026, Above Food Ingredients Inc. (ABVE) is the stronger overall head-to-head candidate over OSR Holdings, Inc. (OSRH) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas OSRH carries 45.0/100 (HOLD) at $0.12 (N/M Forward P/E, -960.8% operating margin).

  • Composite vs. Pillar Nuance: While OSRH currently prints a higher short-term Unified Composite Score (45.0/100 HOLD vs. ABVE 39.8/100 SELL), ABVE captures the overall institutional head-to-head verdict (5–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-23.2% vs. -960.8% operating margin) and revenue trajectory (-45.0% vs. -72.2% YoY).
  • Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile OSRH is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ABVE vs OSRH
ABVE NASDAQ Head-to-Head Winner
Above Food Ingredients Inc. Common Stock
Food And Kindred Products
$0.11
-80.57% 1D
Market Cap $30.0M
TTM Revenue $295M
Forward P/E N/M
Beta / 30D Vol 4.10β · 310% Vol
Unified Composite Score
39.8 / 100 SELL
Tech 40.0 Fund 47.0 Flow 57.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -29.1%), weak momentum, RSI 28
RSI-14: 28.0 · SMA20: $0.55 · SMA50: $0.67
OSRH NASDAQ
OSR Holdings, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.12
-53.4% 1D
Market Cap $8.8M
TTM Revenue $1.8M
Forward P/E N/M
Beta / 30D Vol 0.57β · 390% Vol
Unified Composite Score
45.0 / 100 HOLD
Tech 33.0 Fund 46.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.2%), weak momentum, RSI 32
RSI-14: 32.4 · SMA20: $0.38 · SMA50: $0.38

6-Pillar Scorecard Institutional Category Breakdown (ABVE 6 – 0 OSRH)

Columns: Metric · ABVE · OSRH
1. Valuation Multiples ABVE
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.1x 6.7x
2. Growth & Scale ABVE
Revenue Growth (YoY) -45.0% -72.2%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $295M $1.8M
Market Cap $30.0M $8.8M
3. Profitability & Quality ABVE
Gross Margin -2.8% 33.4%
Operating Margin -23.2% -960.8%
Net Profit Margin -23.4% 0.0%
Return on Equity (ROE) 0.0% -11.3%
4. Balance Sheet & Cash Flow ABVE
Cash Generation (TTM) -$40M EBITDA -$5.4M
Cash Flow Margin -13.7% EBITDA Mgn N/A
Net Cash / Leverage 0.0% ROE $3.4M Net Debt (0.05x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ABVE
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 148.3% (8th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ABVE
OpEx & R&D Intensity 20.4% of Rev ($60M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaged Foods Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ABVE (5) vs OSRH (3)
Institutional Metric ABVE OSRH Criterion Row Edge
Market Capitalization
Scale
$30.0M $8.8M Larger Scale ABVE
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-45.0% -72.2% Higher Growth ABVE
Operating Margin (TTM)
Profitability
-23.2% -960.8% Higher Margin ABVE
Net Profit Margin
Profitability
-23.4% 0.0% Higher Margin OSRH
Return on Equity (ROE)
Capital Efficiency
0.0% -11.3% Higher ROE ABVE
52-Week Range Position
Momentum
0% ($0–$7) 3% ($0–$1) Stronger Trend OSRH
Beta / 30D Volatility
Risk Regime
4.10β · 310% Vol 0.57β · 390% Vol Lower Realized Risk ABVE
Unified Institutional Score
Composite Signal
39.8 / 100 (SELL) 45.0 / 100 (HOLD) Higher Composite OSRH
Trailing 12M Revenue (USD)
Operating Scale
$295M $1.8M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
-2.8% 33.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.1x EV/Rev N/M PEG · 6.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$40M EBITDA (0.0% ROE) -$5.4M ($3.4M Net Debt (0.05x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon OSRH +40.2 pp
ABVE: -79.18% · OSRH: -38.98%
3M Horizon OSRH +96.04 pp
ABVE: -91.43% · OSRH: +4.61%
6M Horizon OSRH +58.84 pp
ABVE: -95.67% · OSRH: -36.83%
1Y Horizon OSRH +77.25 pp
ABVE: -93.97% · OSRH: -16.72%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVE vs OSRH. Trailing 12-month operating profitability (ABVE -23.2% vs OSRH -960.8%) and valuation multiples (ABVE N/M vs OSRH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ABVE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$295M
Gross Margin-2.8%
Op. Margin-23.2%
ROE / Fwd P/E0.0% · N/M
OSRH ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.8M
Gross Margin33.4%
Op. Margin-960.8%
ROE / Fwd P/E-11.3% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ABVE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 148.3%
IV Percentile 8th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ABVE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
OSRH UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact OSRH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ABVE Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $30.0M market capitalization and -23.2% operating margin.
OpEx & R&D Reinvestment 20.4% of Rev ($60M)
90D Engineering Disclosures 0 Published
OSRH Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $8.8M market capitalization and -960.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ABVE vs OSRH Key Questions & Quantitative Answers

As of Aug 25, 2026, Above Food Ingredients Inc. (ABVE) is the stronger overall head-to-head candidate over OSR Holdings, Inc. (OSRH) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas OSRH carries 45.0/100 (HOLD) at $0.12 (N/M Forward P/E, -960.8% operating margin). Composite vs. Pillar Nuance: While OSRH currently prints a higher short-term Unified Composite Score (45.0/100 HOLD vs. ABVE 39.8/100 SELL), ABVE captures the overall institutional head-to-head verdict (5–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-23.2% vs. -960.8% operating margin) and revenue trajectory (-45.0% vs. -72.2% YoY). Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile OSRH is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ABVE leads the Growth & Scale pillar: ABVE posts -45.0% YoY revenue growth and +0.0% YoY earnings growth on $295M TTM revenue (-2.8% gross margin, -23.2% operating margin), compared with OSRH at -72.2% YoY revenue growth and +0.0% YoY earnings growth on $1.8M TTM revenue (33.4% gross margin, -960.8% operating margin). On trailing 12-month operating scale, ABVE generates $295M in USD-normalized revenue versus $1.8M for OSRH. In operating R&D and SG&A reinvestment, ABVE deploys 20.4% of Rev ($60M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for OSRH.

ABVE screens cheaper on headline valuation multiples. ABVE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% EBITDA margin), whereas OSRH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 6.7x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABVE (0.0% ROE) versus OSRH (-11.3% ROE) capital efficiency.

In options market volatility and institutional positioning, ABVE carries 148.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.10β · 310% Vol realized risk). By comparison, OSRH carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.57β · 390% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Aug 25, 2026. For educational research only; not investment advice.